The article emphasizes the critical role of comprehensive risk management in clinical trials, especially as studies grow more complex and face new challenges. It discusses how proactive risk mitigation strategies, tailored to the entire trial lifecycle, can help reduce potential disruptions and ensure high-quality data. The piece also clarifies the distinction between risk management and risk-based monitoring, which is a focused aspect of the broader risk management approach.
